Drugs / KCl
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT05411991 Background | Jun 2022 → Jul 2024 | heart failure | Vrije Universiteit Brussel | Completed | Missed primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KCl | “40 mmol KCl is added if serum potassium levels are” NCT05411991 ↗ |